BSE Live
Apr 20, 11:35Prev. Close
350.85
Open Price
356.45
Bid Price (Qty.)
349.50 (5)
Offer Price (Qty.)
351.05 (47)
NSE Live
Apr 20, 11:35Prev. Close
351.20
Open Price
351.20
Bid Price (Qty.)
349.35 (28)
Offer Price (Qty.)
350.00 (35)
| Balance Sheet of Unichem Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 | |
| Total Share Capital | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 | |
| Reserves and Surplus | 2,436.51 | 2,345.27 | 2,409.18 | 2,593.65 | 2,535.00 | |
| Total Reserves and Surplus | 2,436.51 | 2,345.27 | 2,409.18 | 2,593.65 | 2,535.00 | |
| Total Shareholders Funds | 2,450.59 | 2,362.42 | 2,435.30 | 2,618.41 | 2,556.83 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 60.81 | 38.22 | 63.65 | 89.01 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 13.70 | |
| Other Long Term Liabilities | 25.83 | 25.02 | 12.59 | 19.26 | 19.00 | |
| Long Term Provisions | 37.86 | 35.80 | 41.91 | 39.96 | 30.41 | |
| Total Non-Current Liabilities | 124.50 | 99.05 | 118.14 | 148.24 | 63.12 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 369.16 | 180.93 | 233.74 | 241.35 | 100.63 | |
| Trade Payables | 402.55 | 299.37 | 290.69 | 183.19 | 210.08 | |
| Other Current Liabilities | 84.96 | 91.73 | 103.16 | 111.50 | 180.23 | |
| Short Term Provisions | 137.64 | 135.85 | 12.01 | 16.09 | 14.83 | |
| Total Current Liabilities | 994.31 | 707.88 | 639.60 | 552.13 | 505.76 | |
| Total Capital And Liabilities | 3,569.40 | 3,169.34 | 3,193.05 | 3,318.77 | 3,125.71 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,279.32 | 1,194.43 | 1,255.12 | 988.49 | 882.41 | |
| Intangible Assets | 18.70 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 30.67 | 122.71 | 147.45 | 493.81 | 567.50 | |
| Fixed Assets | 1,328.69 | 1,317.14 | 1,402.57 | 1,482.30 | 1,449.91 | |
| Non-Current Investments | 0.02 | 0.02 | 0.16 | 0.28 | 155.59 | |
| Deferred Tax Assets [Net] | 25.78 | 6.78 | 10.11 | 4.36 | 13.95 | |
| Long Term Loans And Advances | 0.14 | 0.13 | 0.13 | 0.12 | 0.07 | |
| Other Non-Current Assets | 175.27 | 146.23 | 186.66 | 181.78 | 127.33 | |
| Total Non-Current Assets | 1,531.45 | 1,471.84 | 1,601.17 | 1,670.38 | 1,748.40 | |
| CURRENT ASSETS | ||||||
| Current Investments | 778.81 | 1.34 | 1.54 | 263.58 | 236.43 | |
| Inventories | 988.74 | 704.68 | 625.23 | 600.22 | 538.34 | |
| Trade Receivables | 0.00 | 610.40 | 588.62 | 495.43 | 250.27 | |
| Cash And Cash Equivalents | 117.63 | 154.32 | 185.36 | 114.10 | 82.45 | |
| Short Term Loans And Advances | 0.06 | 0.04 | 0.06 | 0.05 | 0.04 | |
| OtherCurrentAssets | 152.71 | 226.73 | 191.07 | 175.01 | 269.78 | |
| Total Current Assets | 2,037.95 | 1,697.51 | 1,591.88 | 1,648.39 | 1,377.32 | |
| Total Assets | 3,569.40 | 3,169.34 | 3,193.05 | 3,318.77 | 3,125.71 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 154.73 | 78.64 | 221.70 | 145.39 | 561.98 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 11.36 | 11.36 | 11.36 | 11.36 | 11.36 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.14 | 0.26 | 0.15 | |
| Non-Current Investments Unquoted Book Value | 0.02 | 0.02 | 0.02 | 0.02 | 155.44 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 1.34 | 1.25 | 263.58 | 236.43 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.29 | 0.00 | 0.00 |
10.02.2026
Unichem Labs Consolidated December 2025 Net Sales at Rs 521.17 crore, down 2.24% Y-o-Y
09.02.2026
Unichem Labs Standalone December 2025 Net Sales at Rs 314.90 crore, down 29.68% Y-o-Y
03.02.2026
17.11.2025
Unichem Labs Consolidated September 2025 Net Sales at Rs 578.96 crore, up 25.27% Y-o-Y
10.02.2026
Unichem Labs Consolidated December 2025 Net Sales at Rs 521.17 crore, down 2.24% Y-o-Y
09.02.2026
Unichem Labs Standalone December 2025 Net Sales at Rs 314.90 crore, down 29.68% Y-o-Y
17.11.2025
Unichem Labs Consolidated September 2025 Net Sales at Rs 578.96 crore, up 25.27% Y-o-Y
12.08.2025
Unichem Labs Consolidated June 2025 Net Sales at Rs 526.60 crore, up 17.96% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth